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A B S T R A C T
Background: Colombia detected its first coronavirus disease 2019 (COVID-19) case on March 2, 2020. From
March 22 to April 25, it implemented a national lockdown that, apparently, allowed the country to keep a
low incidence and mortality rate up to mid-May. Forced by the economic losses, the government then
opened many commercial activities, which was followed by an increase in cases and deaths. This paper
presents a critical analysis of the Colombian surveillance data in order to identify strengths and pitfalls of
the control measures.
Methods: A descriptive analysis of PCR-confirmed cases between March and July 25 was performed. Data
were described according to the level of measurement. Incidence and mortality rates of COVID-19 were
estimated by age, sex, and geographical area. Sampling rates for suspected cases were estimated by
geographical area, and the potential for case underestimation was assessed using sampling differences.
Results: By July 25, Colombia (population 50 372 424) had reported 240 745 cases and 8269 deaths (case
fatality rate of 3.4%). A total of 1 370 271 samples had been analyzed (27 405 samples per million people),
with a positivity rate of 17%. Sampling rates per million varied by region from 2664 to 158 681 per million,
and consequently the incidence and mortality rates also varied. Due to geographical variations in
surveillance capacity, Colombia may have overlooked up to 82% of the actual cases.
Conclusion: Colombia has a lower case and mortality incidence compared to other South American
countries. This may be an effect of the lockdown, but may also be attributed, to some extent, to
geographical differences in surveillance capacity. Indigenous populations with little health infrastructure
have been hit the hardest.
© 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
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Coronavirus disease 2019 (COVID-19) is a new emerging
infectious disease, and more than 17 million cases and more than* Corresponding author at: Universidad de la Costa-CUC, Calle 58 # 55 - 66,
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).680 000 deaths had been reported worldwide by August 1, 2020
(World Health Organization, 2020b). It has been declared a
pandemic by the World Health Organization (WHO) and has
prompted lockdowns of over 2 months in most countries (World
Health Organization, 2020a). The virus has the potential to
transmit from symptomatic and asymptomatic individuals, which
has made it difficult to control its spread around the globe.
Colombia identified its first imported case of COVID-19 on
March 2, and by July 25 had reported 240 745 cases and 8269ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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incidence compared to other countries in Latin America (Pan
American Health Organization, 2020). It has been postulated that
this relatively mild behavior of the virus may be explained in part
by the lockdown and by demographic features of the population,
considering that 86.4% of the Colombian population are under 60
years of age (Departamento Administrativo Nacional de Estadís-
tica, 2018).
The mild impact of the COVID-19 pandemic in Colombia is
unexpected, given that it is one of the most unequal countries in a
very unequal region of the world, with a health system that,
despite having high population insurance coverage (94.6%)
(Ministerio de Salud y Protección Social, 2018), still struggles to
provide good quality healthcare services. In addition, a large
number of hospitals are currently underfunded, since financial
resources flow from health insurance organizations (HIO) to
hospitals through a cumbersome process in which the HIOs have
the upper hand and can leverage multiple strategies in order to
block payments after a service has been provided. Currently, HIOsFigure 1. Numbers of deaths, cases, and recovered cases by date of onset of are withholding more than US$ 3 billion from hospitals for
individual health services provided from 2000 through 2019, a
debt that doubled over the last 5 years (Asociación Colombiana de
Hospitales y Clínicas, 2019).
Given the structural shortcomings of the Colombian health care
system, the apparentgoodstanding of the countryduring the COVID-
19 pandemic is a positive but unexpected outcome. This article
presents the results of a critical analysis of the epidemiological data
from the pandemic in Colombia, 5 months after the report of the first
case, and tries to explore the reasons behind the apparent success of
Colombia in maintaining a low number of COVID-19 cases.
Methods
Study design
This is a descriptive analysis of PCR-confirmed COVID-19 cases
that occurred in Colombia from March 2 to July 25, 2020.
EpidemiologicaldataarecuratedbytheColombianNationalInstitutesymptoms of COVID-19 in Colombia and its regions up to July 25, 2020.
Table 1
Characteristics of the population with COVID-19; Colombia, July 25, 2020.
Variable N = 240 795 %
Sex
Male 128 979 53.6
Female 111 816 46.4
Age (years)
0–9 8971 3.7
10–19 15 546 6.5
20–29 52 848 21.9
30–39 56 989 23.7
40–49 39 251 16.3
50–59 31 585 13.1
60–69 19 051 7.9
70–79 10 182 4.2
80–89 6372 2.6
Clinical presentations
Asymptomatic 32 994 13.7
Mild 183 899 76.4





Intensive care unit (ICU) 1517 0.7
Hospitalized 12 613 5.4
Home care 98 241 42.2




Related 18 796 7.8
In studya 221 030 91.8
NA, not available.
a Cases likely associated to local transmission, with no link to imported cases.
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of the epidemiological data can be found at https://www.ins.gov.co/
Noticias/Paginas/Coronavirus.aspx (Instituto Nacional de Salud,
2020a). The INS is the head of the Colombian national surveillance
system. It provides technical advice on public health surveillance to
local healthcare institutions and coordinates the field investigation
of cases and the confirmatory laboratory testing for COVID-19 cases.
Case definitions
Case and severity of disease definitions used for the surveillance
of COVID-19 are provided by the INS and can be fully accessed at
the following URL: http://www.ins.gov.co/Noticias/Coronavirus/
Estrategia%20VSP%20COVID-19%2023072020.pdf. From March to
June, RT-PCR was predominantly recommended for symptomatic
cases with a history of travel or contact with travelers, despite the
fact that local transmission replaced imported transmission
starting in April. Only in July were testing criteria expanded to
include symptomatic and asymptomatic suspected cases with or
without risk factors.
Variables
The INS database contains the following information: (1) dates
of symptom onset, sample taking, epidemiological reporting,
laboratory diagnosis, recovery, and death; (2) age and sex; (3) city
of residence; (4) severity of disease classified as asymptomatic,
mild, moderate, and severe; (5) place where health care is provided
stratified by hospital care, intensive care unit (ICU), or home care.
Analysis
Data were described according to the level of measurement.
Proportions were used for nominal or ordinal variables, and means
or medians were used for continuous variables. Incidence rates of
confirmed COVID-19 cases were estimated by department (state)
and for several municipalities stratified by age and sex. COVID-19
mortality rates were also estimated by department and for selected
municipalities stratified by age and sex.
The capacity of the departmental surveillance systems was
assessed using several indicators: (1) cumulated proportion of
samples taken per million people by department; (2) mean
number of positive contacts for every imported case; (3) average
interval in days between the onset of symptoms and date of
diagnosis; (4) average interval in days from the date when the case
was detected to the date of diagnosis.
A conservative assessment of the potential underestimation of
cases was done using the following approach: (1) the ratio of
samples taken per million people by department and district was
estimated and the geographical area with the highest ratio was
identified. (2) That ratio was projected to the population of every
department/district, in order to estimate the ‘potential number of
samples’ that the surveillance system would have obtained if the
same effort had been made for every geographical area. (3) The
positivity ratio of samples by department was obtained by dividing
the number of positive samples in a department/district by the
total number of samples taken in that department. (4) A ‘potential
number of cases’ by department was obtained by multiplying the
‘potential number of samples’ of a particular department by its
positivity ratio (see Supplementary Material Table S1).
A visual analysis of how COVID-19 was disseminated around the
country during the first month of transmission was performed by
mapping departments and municipalities where local cases – not
linked to imported transmission – were detected during March
2020. Also, these territories were aggregated into geographic
regions to describe the differential trends in the number of cases(mild, moderate, severe) and deaths (Supplementary Material
Figure S1).
All data were analyzed using Microsoft Excel, Epi Info 7.2, Stata
12 (Stata Corporation, College Station, TX, USA), and Python v3.6
(packages: Pandas, Geopandas, Matplotlib, and Seaborn).
Results
General characteristics of COVID-19 cases
By July 25, Colombia had confirmed 240 795 cases of COVID-19
and 8269 deaths, with differential trends by geographic region
(Figure 1). Males accounted for 53.6% of cases, while 72% of cases
occurred in persons aged 0–49 years (Table 1). Most cases (90.1%)
were asymptomatic or presented with mild clinical manifesta-
tions, 0.7% were in the ICU and 51.5% have recovered so far. The
cumulated incidence of infection was 478 per 105 persons and the
average incidence density was 97.6 cases per 105 person-months.
The incidence rate was lower among persons <20 years of age (<50
cases per 105 person-months), and it increased to more than 100
cases per 105 person-months among adults >20 years of age. The
case incidence was higher in males than in females (524 vs 434
cases per 105 persons, respectively) (Table 2).
The case fatality rate (CFR) was 3.4% and the specific cumulated
mortality rate was 16.4 per 105 persons. The CFR increased by age
group, from less than 1% among younger people (0–39 years) to
more than 30% among the oldest (80 years and older). The specific
mortality rate also increased from less than 1 per 105 among
younger people (<20 years old) to more than 200 per 105 people
among the oldest (>80 years old). The CFR was higher among males
compared to females (4.3% vs 2.4%, respectively) and the same
trend was observed for the mortality rate (21.3 vs 11.8 cases per
105) (Table 2).
Table 2
Incidence, mortality, and fatality in the population with COVID-19, according to age groups; Colombia, July 25, 2020.










CFR (%) Mortality rate
per 105 persons
Total
0–9 7 863 825 38 532 743 8971 14 114 23.3 0.2% 0.2
10–19 8 112 327 39 750 402 15 546 11 192 39.1 0.1% 0.1
20–29 8 551 856 41 904 094 52 848 107 618 126.1 0.2% 1.3
30–39 7 470 681 36 606 337 56 989 269 763 155.7 0.5% 3.6
40–49 6 130 204 30 038 000 39 251 612 640 130.7 1.6% 10.0
50–59 5 434 890 26 630 961 31 585 1181 581 118.6 3.7% 21.7
60–69 3 795 322 18 597 078 19 051 1894 502 102.4 9.9% 49.9
70–79 2 003 827 9 818 752 10 182 2081 508 103.7 20.4% 103.9
80+ 1 009 492 4 946 512 6372 2100 631 128.8 32.9% 208.0
Total 50 372 424 246 824 878 240 795 8269 478 97.6 3.4% 16.4
Male
0–9 4 018 776 19 692 002 4523 9 113 23.0 0.2% 0.2
10–19 4 132 721 20 250 333 8197 6 198 40.5 0.1% 0.1
20–29 4 281 591 20 979 796 28 123 65 657 134.0 0.2% 1.5
30–39 3 654 091 17 905 046 31 040 167 849 173.4 0.5% 4.6
40–49 2 916 820 14 292 418 20 965 446 719 146.7 2.1% 15.3
50–59 2 524 743 12 371 241 17 021 812 674 137.6 4.8% 32.2
60–69 1 735 695 8 504 906 10 305 1213 594 121.2 11.8% 69.9
70–79 897 276 4 396 652 5597 1328 624 127.3 23.7% 148.0
80+ 433 169 2 122 528 3208 1193 740 151.1 37.2% 275
Total 24 594 882 120 514 922 128 979 5239 524 107.0 4.1% 21.3
Female
0–9 3 845 049 18 840 740 4448 5 116 23.6 0.1% 0.1
10–19 3 979 606 19 500 069 7349 5 185 37.7 0.1% 0.1
20–29 4 270 265 20 924 299 24 725 42 579 118.2 0.2% 1.0
30–39 3 816 590 18 701 291 25 949 102 680 138.8 0.4% 2.7
40–49 3 213 384 15 745 582 18 286 166 569 116.1 0.9% 5.2
50–59 2 910 147 14 259 720 14 564 369 500 102.1 2.5% 12.7
60–69 2 059 627 10 092 172 8746 681 425 86.7 7.8% 33.1
70–79 1 106 551 5 422 100 4585 753 414 84.6 16.4% 68.0
80+ 576 323 2 823 983 3164 907 549 112.0 28.6% 157.4
Total 25 777 542 126 309 956 111 816 3030 434 88.5 2.7% 11.8
CFR, case fatality rate.
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were apparently free of COVID-19 (26%) and 373 (33.2%) had seen
limited transmission. The incidence rate by department ranged
from 1.8 to 3160 cases per 105 people, with the highest rate
reported in Amazonas (seven times the average national rate), a
southern region that shares borders with Brazil and Peru. Another
four departments (Atlántico, Caquetá, Cesar, and Sucre) and four
special districts (Bogotá DC, Barranquilla DE, Buenaventura DE, and
Santa Marta DT) exceeded the national average rate (Table 3).
Figure 1 shows the epidemic curve for the country and for the
five main geographical areas. It suggests that widespread
transmission started in June, after the lockdown was relaxed
and gradual opening of commercial activities had started. By May
16, after 14 weeks of transmission, Colombia had reported 15 000
cases and 560 deaths, and by June 15, 5 weeks later, the number of
cases had tripled (47 000 cases and 1545 deaths). Early peaks of
transmission were detected in the Amazon, which started while
the lockdown was still in place.
Specific mortality rates by department ranged from 0 in
Vichada to 1278 in Amazonas, which had 7.8 times the national
rate (Incidence Rate Ratio (IRR) = 7.8, 95% confidence interval (CI)
6.4–9.5). Eight additional areas (Atlántico, Barranquilla DE, Bogotá
DC, Buenaventura DE, Caquetá, Chocó, Santa Marta DT, and Sucre)
surpassed the national mortality rate (Table 3).
The average age increased with the severity of clinical
presentation, being 37.5 years (standard deviation (SD) 17.6 years)
for mild disease, 51.9 years (SD 20.5 years) for moderate disease,
54.6 years (SD 19.7 years) for severe clinical presentations, and 68.1
years (SD 16.5 years) for people who died. These differences
persisted by geographical area (Table 4).Selected surveillance characteristics
The Colombian surveillance system had taken 1 370 271
samples (27 203 samples per million people), but there was wide
variability in the number of samples taken by department (range
2664 to 158 681/106). The positivity ratio (number of cases/
number of samples) varied from 0.2% to 79.3%, with a national
average of 17% (Supplementary Material Table S1).
It took a median of 11 days to confirm a case from the date of
symptom onset (interquartile range (IQR) 2 days) and 5.6 days
from the date of case detection by the health system (IQR 1.7 days).
A median of 5 days passed from the beginning of symptoms to case
detection (IQR 1.9 days) (Supplementary Material Table S2).
By July 25, 92% of Colombian cases were likely linked to local
transmission, while imported cases and those related to imported
cases represented 0.4% and 7.8%, respectively. Bogotá DC, Anti-
oquia, and Valle del Cauca had most of the imported cases – 68%
out of 969 imported cases – detected by surveillance across the
country. There were 18 796 imported-related cases and most of
them were identified in Bogotá DC (n = 5151), Antioquia (n = 2156),
Valle del Cauca (n = 1806), and Meta (n = 1140). At the national
level, one imported case was associated with 20 contact cases
(related cases) (Supplementary Material Table S3).
Imported cases came from Europe (39%), other Latin American
countries (29%), North America (26%), the Middle East (6%), Africa
(0.4%), and Australia (0.1%). Spain and the USA were the individual
countries from which most imported cases came (258 and 207
cases, respectively). No cases from China were detected.
In March, local transmission (cases without a history of travel or
contact with travelers) was identified in 14 different geographical
Table 3
Distribution of cases and death rates by department; Colombia, July 25, 2020.
Department Population Cases Cumulative incidence 105 Deaths Mortality rate 106 CFR (%)
Amazonas 79 020 2497 3160.0 101 1278.2 4.0
Antioquia 6 677 930 23 035 344.9 321 48.1 1.4
Arauca 294 206 181 61.5 1 3.4 0.6
Archipielago of San Andrés, Providencia and Santa Catalina 63 692 33 51.8 – – –
Atlántico 1 447 878 20 485 1414.8 961 663.7 4.7
Barranquilla DE 1 274 250 27 088 2125.8 1399 1097.9 5.2
Bogotá DC 7 743 955 81 180 1048.3 2115 273.1 2.6
Bolívar 1 152 240 2028 176.0 93 80.7 4.6
Boyacá 1 242 731 759 61.1 25 20.1 3.3
Buenaventura DE 311 827 1998 640.7 131 420.1 6.6
Córdoba 1 828 947 651 63.9 9 8.8 1.4
Caldas 1 018 453 542 132.0 8 19.5 1.5
Cartagena 410 521 213 48.9 4 9.2 1.9
Caquetá DT 1 028 736 14 258 1 386 440 427.7 3.1
Casanare 435 195 1501 100.6 44 29.5 2.9
Cauca 1 491 937 2447 188.9 49 37.8 2.0
Cesar 1 295 387 2802 514.4 89 163.4 3.2
Chocó 544 764 3593 196.5 438 239.5 12.2
Cundinamarca 3 242 999 6928 213.6 161 49.6 2.3
Guainía 50 636 14 27.6 1 19.7 7.1
Guaviare 86 657 77 88.9 – 0.0 0.0
Huila 1 122 622 673 59.9 18 16.0 2.7
La Guajira 965 718 1757 181.9 103 106.7 5.9
Magdalena 888 414 1878 211.4 181 203.7 9.6
Meta 1 063 454 2256 212.1 27 25.4 1.2
Nariño 1 627 589 6610 406.1 197 121.0 3.0
Norte de Santander 1 620 318 1515 93.5 59 36.4 3.9
Putumayo 359 127 532 148.1 22 61.3 4.1
Quindío 555 401 245 44.1 6 10.8 2.4
Risaralda 961 055 1298 135.1 25 26.0 1.9
Santa Marta DT 538 612 3049 566.1 130 241.4 4.3
Santander 2 280 908 2564 112.4 64 28.1 2.5
Sucre 949 252 5119 539.3 327 344.5 6.4
Tolima 1 339 998 2049 152.9 38 28.4 1.9
Valle del Cauca 4 220 325 18 877 447.3 681 161.4 3.6
Vaupés 44 712 61 136.4 1 22.4 1.6
Vichada 112 958 2 1.8 – 0.0 0.0
CFR, case fatality rate.
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area of the country did not report such cases at that time (Figure 2).
Using a conservative approach to assess the potential underes-
timation of cases, it was estimated that, by July 25, Colombia
should have detected 1 328 175 cases instead of the actual 240 795
observed, an underestimation of 82% (Supplementary Material
Table S1).
Discussion
After approximately 140 days of COVID-19 transmission in
Colombia, the numbers of cases and deaths were extremely low
compared to projections. A mathematical model estimated that 21
237 000 cases and 212 000 deaths would occur in the first 100 days
of the epidemic without interventions (Instituto Nacional de Salud,
2020b). However, only 0.3% of forecasted cases and 0.7% of
forecasted deaths were reported after those first 100 days.
On comparison to other Latin American countries, Colombia
had a lower incidence rate per 105 people (478/105), than Peru
(1212/105), Panama (1507/105), Chile (1819/105), Brazil (1157/105),
and Bolivia (636/105). Its mortality rate (17/105) was lower than
Brazil (42/105), Chile (49/105), Panama (33.8/105), Mexico (33/105),
and Ecuador (32.8/105). In addition, it had a higher rate of sampling
than most Latin American countries except Chile, Panama, and
Uruguay (Hasell et al., 2020).
One factor explaining Colombia’s seeming success in containing
the pandemic is the enforcement of a strict lockdown early on. On
March 18, 2020, the Colombian government released Decree 420
(Ministerio del Interior) closing schools and universities,cancelling almost all in-person work activities, stopping national
and international land and air travel, cancelling all public and
private gatherings (of more than six persons), and imposing self-
isolation for people over 70 years of age, among other measures
(Ministerio del Interior, República de Colombia, 2020a). These
regulations were in place until the first week of May, when a
reactivation of economic activities began (Ministerio del Interior.
República de Colombia, 2020). In addition, Colombia, through the
Colombian Association of Infectious Diseases (ACIN, the acronym
in Spanish), promptly generated a consensus for the management
of COVID-19 cases (Asociacio’n Colombiana de Infectologi’a and
IETS, 2020; Marin et al., 2020), establishing criteria to manage
cases at home, which may have contributed to decreasing the rate
of nosocomial infections, an important source of transmission.
The decision in Colombia to implement an early lockdown
contrasted with actions taken by other countries in the region. The
governments of Brazil and Mexico ignored the potential threat of
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
and, as a result, they have been hit hard. However, other countries
that implemented lockdowns (Chile and Peru) have also had higher
rates of deaths and cases than Colombia, which may be explained
by differences in the efficacy of the lockdown, differences in
testing, and social and climatic conditions, some of which will need
to be studied in the future (Villalobos et al., 2020; Perez-Brumer
and Silva-Santisteban, 2020).
There is no experimental evidence on the effectiveness of social
distancing measures, but modelling approaches consistently show
that they are followed by a sharp decline in cases and deaths
(Institute for Health Metrics and Evaluation (IHME) 2020; Kennedy
Table 4
Average age (years) by COVID-19 severity by department; Colombia, July 25, 2020.
Department Deaths Severe Moderate Mild Total
Amazonas 68.3 54.5 48.3 35.2 36.9
Antioquia 71.7 55.4 52.4 36.6 37.9
Arauca 42.0 19.5 36.6 28.1 28.4
Archipielago of San Andrés, Providencia and Santa Catalina – – – 37.4 37.4
Atlántico 66.4 53.9 50.8 37.9 39.9
Barranquilla DE 68.0 57.3 53.8 38.5 40.7
Bogotá DC 68.8 54.2 52.9 37.4 40.1
Bolívar 69.3 50.0 49.6 37.2 39.7
Boyacá 69.4 59.0 50.8 38.7 41.2
Buenaventura DE 67.3 52.3 54.4 35.8 39.5
Córdoba 72.1 64.0 52.7 40.2 41.5
Caldas 71.0 42.3 47.7 34.7 36.6
Caquetá 67.4 57.6 51.5 37.6 39.1
Cartagena DT 62.0 61.0 43.8 36.2 37.6
Casanare 69.9 54.1 50.4 35.9 38.6
Cauca 66.2 46.1 39.2 35.2 36.2
Cesar 62.7 49.9 50.7 36.2 38.2
Chocó 67.1 53.0 50.1 39.7 44.7
Cundinamarca 65.0 55.2 53.1 36.7 38.8
Guainía 73.0 – – 27.6 33.3
Guaviare – – 46.0 26.6 27.4
Huila 70.8 66.0 48.6 38.3 39.8
La Guajira 64.6 50.9 48.2 36.7 39.3
Magdalena 68.8 43.3 52.7 38.9 43.4
Meta 67.6 51.7 47.3 34.5 35.6
Nariño 65.8 48.9 47.2 36.9 38.6
Norte de Santander 64.5 48.6 52.3 38.2 40.9
Putumayo 60.0 31.6 44.2 36.5 38.7
Quindío 70.3 – 56.6 45.2 46.4
Risaralda 66.6 53.2 52.8 37.0 38.4
Santa Marta DT 66.4 49.6 48.0 37.5 39.6
Santander 68.2 62.5 53.1 36.9 39.6
Sucre 70.4 56.4 52.0 38.1 41.9
Tolima 67.1 62.8 61.9 36.1 37.6
Valle del Cauca 69.7 57.1 52.4 38.1 40.6
Vaupés 70.0 – – 36.1 36.9
Vichada – – 78.0 – 78.0
Total 68.1 54.6 51.9 37.5 39.8
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the department of Cundinamarca as evidence of the success of the
lockdown imposed in Bogotá DC, the country’s capital. Bogotá DC is
surrounded by a myriad of Cundinamarca’s municipalities,
containing around three million people, and there is continuous
mobility of people from and to Bogotá DC. The lockdown stopped
this mobility, and so far Cundinamarca has had an incidence rate
approximately five times lower than Bogotá DC.
Two additional factors may have influenced the low incidence
and mortality rates: weather and demographic profile. In
Colombia, peaks of respiratory virus transmission and related
mortality occur mostly during rainy seasons (Porras Ramírez et al.,
2009; Cotes et al., 2012). However, since October 2019, the country
has experienced an unusually longer dry season that has extended
through June 2020 (El Tiempo, 2020). This year, the rainy season
started late in June in most regions of the country, coinciding with
the end of the lockdown. The potential role of both factors in the
increase in cases and deaths observed after May has yet to be
ascertained. In addition, Colombia has a relatively young popula-
tion, which may have attenuated the SARS-CoV-2 impact on
mortality (Amariles et al., 2020).
Underreporting and surveillance weaknesses may also have
contributed to hide the real numbers of cases and deaths in
Colombia. Colombia kept a conservative case definition (see
Methods) for the first 2.5 months of transmission because of
shortages in biological and laboratory supplies to perform PCR
tests. While stringent criteria for sampling and testing may
succeed in keeping demand at bay, they also contribute to the
underestimation of cases.Some surveillance indicators suggest that Colombia may have
missed a substantial number of cases. First, the sampling ratio was
found to differ widely by department. Results in Supplementary
Material Table S1 suggest that if the sampling ratio in Amazonas
had been reached by other departments, the number of cases
would have increased eight-fold. Second, the ratio of COVID-19-
positive contacts per imported case suggests that some depart-
ments were unable to track most imported cases. In three
departments/districts with the highest incidence rates, the ratio
of positive contacts to imported cases was four to 12 times the
national average (19 to 1). Although super-spreaders of COVID-19
may exist, large ratios of positive contacts to imported cases
suggest a lack of capacity to detect and track all imported cases
(Pung et al., 2020).
Although the first imported case was detected on March 2, it is
highly likely that transmission started in February or even in late
January. The map in Figure 2 shows that there was simultaneous
detection of local cases without known links to imported cases in
several distant areas in March. One of the first cases reported
symptoms on February 29, several days before the first imported
case was detected. The role of undetected transmission during
February in the subsequent pattern of disease spread is difficult to
establish given the limitations in testing during March and April.
Colombia has increased its surveillance capacity. It jumped
from taking less than 3000 samples/week in the first week to >600
000 in July (Supplementary Material Table S4). However, wide
gaps between departments remain. The three largest cities have
60% (36/60) of the laboratories able to perform PCR testing,
whereas 12 out of 33 departments have no such facilities. Public
Figure 2. Local cases of COVID-19 by municipality, March 2020.
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hampers their ability to detect and track contacts.
As reported by others, age is one of the strongest predictors of
mortality (Cagnacci and Xholli, 2020; Immovilli et al., 2020).
Patients who died were on average older (68 years) than those with
mild cases (37 years). In Wuhan, the average age among those who
died was 68 years (Chen et al., 2020). Wu et al. first reported that
the CFR increases with age. However, the CFR in people aged 70
years and older was lower in Wuhan than in Colombia (14% vs 25%)
(Wu and McGoogan, 2020).
Mortality in Colombia varied by geographic region and this may
have been related to the availability of ICU beds and quality of care.
Public discussions have centered around the number of ICUs with
ventilators available in the country, and whether there will be
enough to cope with the potential demand produced by COVID-19
(Amariles et al., 2020). Another caveat is the availability of
healthcare workers. For example, the only hospital covering the
Amazonas population (79 020 inhabitants) has five ICU beds withventilators, but lacks personnel trained in critical care. The impact
of these shortcomings is reflected in the high mortality rate
observed there (approximately eight times the national average),
surpassing even the mortality rates observed in Peru (21/105),
Brazil (20/105), and Ecuador (23/105). Regional inequalities in the
pandemic response capacity and their relationship to mortality in
Colombia, mirror those described in China (Ji et al., 2020).
This analysis has limitations. We did not have access to clinical
records of infected individuals. Therefore, it was not possible to
assess the role of chronic underlying diseases in the mortality by
COVID-19. The INS has published a list of the frequency of
comorbidities in COVID-19 patients who have died, including
hypertension (28%), diabetes (15%), chronic obstructive pulmonary
disease (12%), obesity (8%), history of smoking (5%), and
hypothyroidism (4%); 13% have had no underlying diseases.
However, it is not possible to know how many concurrent diseases
were present in each patient, or how they compare to individuals
with milder presentations.
F. De la Hoz-Restrepo et al. / International Journal of Infectious Diseases 99 (2020) 522–529 529One strength of the present study is that it provides a critical
overview of the potential explanations for the apparent success of
Colombia in mitigating the effect of the pandemic. As well as
discussing the effect of the preventive measures adopted by the
government, we have discussed the role that weaknesses in the
surveillance system, as well as sociodemographic and climatic
factors, may have had in the unexpected positive results. This
analysis provides a baseline for monitoring the impact that
changes in containment strategy, such as relaxing lockdown
measures on May 15, may have on COVID-19 transmission. It may
also help to assess the impact of the ongoing improvements in
laboratory capacity that Colombia is implementing.
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